Novo Nordisk's financial strength is evident through its 74% historical average ROIC and 85% gross margin. See why I rate NVO ...

Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs ...

Award to support the development of molecules to inhibit BamA protein Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award a seed grant of US$610k to Justus Liebig ...

However, when the sample was expanded to include those who ... eagerly awaited in the pharmaceutical industry this year. Novo Nordisk had been banking on the success of CagriSema to maintain ...

New research from University of Iowa dispels the belief that pharmaceutical mergers lead to higher drug prices, showing a decrease in prices for generic drugs.

At the time, drugmakers were establishing partnerships with biological repositories such as UK Biobank, which contains biological samples and ... The new Novo Nordisk deal kicks off a second ...

Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop ...

UK Biobank has today announced the launch of the world’s most comprehensive study of the proteins circulating in our bodies, which will transform the study of diseases and their treatments.

Analyst recommends Novartis as a Buy for long-term investors, BioAge a Hold, following strategic partnership for age-related ...

The collection includes 173 samples from North America ... The work was also supported by the Novo Nordisk Foundation under ...

Global spread of powdery mildew threatens blueberries, costing millions and prompting better disease management strategies.

Surgeons are collaborating with obesity medicine physicians, turning to GLP-1s to help high BMI patients qualify for surgery.